Myers Scott Dunseth - Insider Non-Derivative Transactions at Viridian Therapeutics, Inc.\DE (VRDN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 12, 2023, Myers Scott Dunseth's relationship to Viridian Therapeutics, Inc.\DE (VRDN) is Director,Officer (Chief Executive Officer), and currently has 259,500 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other VRDN insiders.
Data Source: SEC.
Myers Scott Dunseth - Insider Non-Derivative Transactions of VRDN Common Stock
Myers Scott Dunseth - Insider Non-Derivative Transactions at VRDN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 13, 2023 | P -- (Common Stock) | 4000 | 25.37 | 259500 |
| Mar 14, 2023 | P -- (Common Stock) | 5500 | 29.15 | 255500 |
| Feb 7, 2023 | Acquisition -- (Common Stock) | 250000 | 0 | 250000 |